After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care.
Jan 19, 2022
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
Aug 5, 2013
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure
Sep 26, 2017
Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months
Jun 4, 2019